Vanderbilt University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1873-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.vanderbilt.edu
The Role of Endothelin in the Supine Hypertension of Autonomic Failure
Phase 1
Withdrawn
- Conditions
- HypertensionPure Autonomic FailureMultiple System Atrophy
- Interventions
- Drug: Saline
- First Posted Date
- 2010-05-07
- Last Posted Date
- 2021-10-05
- Lead Sponsor
- Vanderbilt University
- Registration Number
- NCT01119417
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
The Measurement of Insulin Resistance in Peritoneal Dialysis Patients
Not Applicable
Completed
- Conditions
- End Stage Renal Disease
- Interventions
- Other: Icodextrin dialysate
- First Posted Date
- 2010-05-07
- Last Posted Date
- 2016-09-26
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 10
- Registration Number
- NCT01119196
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Conventional vs Mindfulness Intervention in Parents of Children With Disabilities
Not Applicable
Completed
- Conditions
- Psychological StressDepressionAnxiety
- Interventions
- Behavioral: mindfulness interventionBehavioral: Conventional parent Support Group
- First Posted Date
- 2010-04-26
- Last Posted Date
- 2015-06-04
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 243
- Registration Number
- NCT01110343
- Locations
- 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
Impact of Secondary Lymphedema on Symptoms, Functional Status, and Quality of Life After Treatment in Patients With Head and Neck Cancer
Completed
- Conditions
- Cancer SurvivorHead and Neck CancerLymphedema
- First Posted Date
- 2010-04-05
- Last Posted Date
- 2017-04-07
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 103
- Registration Number
- NCT01098669
- Locations
- 🇺🇸
Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
🇺🇸Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors
Not Applicable
Terminated
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2010-04-05
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 88
- Registration Number
- NCT01098643
- Locations
- 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
🇺🇸Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville, Tennessee, United States
Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial Cancer
Completed
- Conditions
- Ovarian Cancer
- First Posted Date
- 2010-03-31
- Last Posted Date
- 2015-12-10
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 20
- Registration Number
- NCT01096394
- Locations
- 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Pain Relief at Iliac Crest Bone Harvest Sites in Spine Surgery Using Bupivacaine
- First Posted Date
- 2010-03-16
- Last Posted Date
- 2018-06-25
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 40
- Registration Number
- NCT01087931
- Locations
- 🇺🇸
Vanderbilt Medical Center, Nashville, Tennessee, United States
Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant
Terminated
- Conditions
- Cancer SurvivorMyelodysplastic/Myeloproliferative NeoplasmsLymphomaLeukemiaMyelodysplastic SyndromesMultiple Myeloma and Plasma Cell NeoplasmNeuroblastomaChronic Myeloproliferative DisordersTesticular Germ Cell Tumor
- Interventions
- Genetic: DNA analysisGenetic: polymerase chain reactionOther: flow cytometryOther: laboratory biomarker analysis
- First Posted Date
- 2010-03-01
- Last Posted Date
- 2014-12-10
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 24
- Registration Number
- NCT01077440
- Locations
- 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Trial of Antimycobacterial Therapy in Sarcoidosis
Phase 1
Completed
- Conditions
- Sarcoidosis
- Interventions
- Drug: Placebo RegimenDrug: Antibiotic Regimen
- First Posted Date
- 2010-02-24
- Last Posted Date
- 2016-12-12
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 30
- Registration Number
- NCT01074554
- Locations
- 🇺🇸
Vanderbilt University School of Medicine, Nashville, Tennessee, United States
Hydroxychloroquine Efficacy in Chronic Urticaria
Not Applicable
Withdrawn
- Conditions
- Chronic Urticaria
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-02-23
- Last Posted Date
- 2013-01-23
- Lead Sponsor
- Vanderbilt University
- Registration Number
- NCT01073852
© Copyright 2025. All Rights Reserved by MedPath